PTC Short Term Investments from 2010 to 2025

PTCT Stock

USD 46.15 0.93 2.06%

PTC Therapeutics Short Term Investments yearly trend continues to be comparatively stable with very little volatility. Short Term Investments will likely drop to about 281.6 M in 2025. From the period from 2010 to 2025, PTC Therapeutics Short Term Investments quarterly data regression had r-value of 0.45 and coefficient of variation of 85.26. View All Fundamentals

Short Term Investments

First Reported

2004-12-31

Previous Quarter

438.5 M

Current Value

487.4 M

Quarterly Volatility

222 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check PTC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PTC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 156 M, Total Revenue of 1.1 B or Research Development of 804.9 M, as well as many indicators such as Price To Sales Ratio of 2.4, Dividend Yield of 0.0 or Days Sales Outstanding of 51.74. PTC financial statements analysis is a perfect complement when working with PTC Therapeutics Valuation or Volatility modules.

Check out the analysis of PTC Therapeutics Correlation against competitors.

For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.

Latest PTC Therapeutics' Short Term Investments Growth Pattern

Below is the plot of the Short Term Investments of PTC Therapeutics over the last few years. Short Term Investments is an item under the current assets section of PTC Therapeutics balance sheet. It contains any investments PTC Therapeutics undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that PTC Therapeutics can easily liquidate in the marketplace. It is PTC Therapeutics' Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PTC Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Short Term Investments

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Short Term Investments

Timeline

PTC Short Term Investments Regression Statistics

	Arithmetic Mean	260,127,896
	Geometric Mean	187,134,607
	Coefficient Of Variation	85.26
	Mean Deviation	153,986,974
	Median	265,493,000
	Standard Deviation	221,794,472
	Sample Variance	49192.8T
	Range	868.6M
	R-Value	0.45
	Mean Square Error	42258.8T
	R-Squared	0.20
	Significance	0.08
	Slope	20,741,323
	Total Sum of Squares	737891.8T

PTC Short Term Investments History

	2025	281.6 M
	2024	325.1 M
	2023	282.7 M
	2022	130.9 M
	2021	583.7 M
	2020	894.8 M
	2019	398.5 M

Other Fundumenentals of PTC Therapeutics

Cash And Short Term Investments

PTC Therapeutics Short Term Investments component correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Net Receivables	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Capital Surpluse	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.37	0.57	0.72	0.64	0.93	0.81	0.21	0.6	-0.9	0.89	0.95	0.62	0.88	-0.87	0.94	0.86	0.5	0.76	0.85	0.91
Total Stockholder Equity	-0.37		0.04	-0.82	0.18	-0.69	-0.6	0.03	-0.86	0.7	-0.71	-0.49	-0.71	-0.24	0.68	-0.38	-0.73	-0.72	-0.58	-0.23	-0.63
Accounts Payable	0.57	0.04		0.07	0.48	0.42	0.57	0.4	-0.06	-0.49	0.46	0.41	0.13	0.64	-0.5	0.63	0.39	0.11	-0.02	0.36	0.46
Long Term Debt	0.72	-0.82	0.07		0.16	0.9	0.66	-0.13	0.97	-0.86	0.88	0.85	0.88	0.57	-0.79	0.65	0.91	0.79	0.92	0.59	0.82
Short Term Investments	0.64	0.18	0.48	0.16		0.42	0.43	0.36	0.07	-0.36	0.27	0.62	0.24	0.55	-0.26	0.58	0.27	0.32	0.35	0.82	0.51
Total Liab	0.93	-0.69	0.42	0.9	0.42		0.86	0.14	0.82	-0.97	0.97	0.94	0.78	0.78	-0.94	0.87	0.96	0.69	0.84	0.75	0.96
Property Plant Equipment	0.81	-0.6	0.57	0.66	0.43	0.86		0.59	0.55	-0.86	0.85	0.74	0.74	0.7	-0.87	0.78	0.78	0.61	0.55	0.55	0.86
Current Deferred Revenue	0.21	0.03	0.4	-0.13	0.36	0.14	0.59		-0.24	-0.13	0.1	0.04	0.19	0.17	-0.2	0.21	-0.04	0.11	-0.14	0.07	0.18
Net Debt	0.6	-0.86	-0.06	0.97	0.07	0.82	0.55	-0.24		-0.78	0.81	0.76	0.79	0.43	-0.71	0.53	0.85	0.8	0.87	0.53	0.74
Retained Earnings	-0.9	0.7	-0.49	-0.86	-0.36	-0.97	-0.86	-0.13	-0.78		-0.98	-0.9	-0.76	-0.83	0.97	-0.9	-0.96	-0.65	-0.76	-0.69	-0.94
Net Receivables	0.89	-0.71	0.46	0.88	0.27	0.97	0.85	0.1	0.81	-0.98		0.88	0.77	0.79	-0.97	0.86	0.97	0.63	0.78	0.62	0.92
Total Current Assets	0.95	-0.49	0.41	0.85	0.62	0.94	0.74	0.04	0.76	-0.9	0.88		0.75	0.82	-0.8	0.87	0.89	0.69	0.88	0.88	0.92
Short Term Debt	0.62	-0.71	0.13	0.88	0.24	0.78	0.74	0.19	0.79	-0.76	0.77	0.75		0.54	-0.66	0.56	0.74	0.83	0.78	0.46	0.72
Common Stock	0.88	-0.24	0.64	0.57	0.55	0.78	0.7	0.17	0.43	-0.83	0.79	0.82	0.54		-0.79	0.95	0.73	0.37	0.58	0.72	0.82
Net Tangible Assets	-0.87	0.68	-0.5	-0.79	-0.26	-0.94	-0.87	-0.2	-0.71	0.97	-0.97	-0.8	-0.66	-0.79		-0.88	-0.92	-0.52	-0.67	-0.59	-0.9
Capital Surpluse	0.94	-0.38	0.63	0.65	0.58	0.87	0.78	0.21	0.53	-0.9	0.86	0.87	0.56	0.95	-0.88		0.83	0.44	0.64	0.81	0.92
Long Term Debt Total	0.86	-0.73	0.39	0.91	0.27	0.96	0.78	-0.04	0.85	-0.96	0.97	0.89	0.74	0.73	-0.92	0.83		0.65	0.81	0.67	0.93
Short Long Term Debt	0.5	-0.72	0.11	0.79	0.32	0.69	0.61	0.11	0.8	-0.65	0.63	0.69	0.83	0.37	-0.52	0.44	0.65		0.68	0.54	0.67
Net Invested Capital	0.76	-0.58	-0.02	0.92	0.35	0.84	0.55	-0.14	0.87	-0.76	0.78	0.88	0.78	0.58	-0.67	0.64	0.81	0.68		0.74	0.78
Net Working Capital	0.85	-0.23	0.36	0.59	0.82	0.75	0.55	0.07	0.53	-0.69	0.62	0.88	0.46	0.72	-0.59	0.81	0.67	0.54	0.74		0.82
Capital Stock	0.91	-0.63	0.46	0.82	0.51	0.96	0.86	0.18	0.74	-0.94	0.92	0.92	0.72	0.82	-0.9	0.92	0.93	0.67	0.78	0.82

Click cells to compare fundamentals

About PTC Therapeutics Financial Statements

PTC Therapeutics shareholders use historical fundamental indicators, such as Short Term Investments, to determine how well the company is positioned to perform in the future. Although PTC Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in PTC Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on PTC Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Short Term Investments	325.1 M	281.6 M
Cash And Short Term Investments	1 B	1.1 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for PTC Stock Analysis

When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PTC Short Term Investments from 2010 to 2025

Latest PTC Therapeutics' Short Term Investments Growth Pattern

PTC Short Term Investments Regression Statistics

PTC Short Term Investments History

Other Fundumenentals of PTC Therapeutics

PTC Therapeutics Short Term Investments component correlations

About PTC Therapeutics Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for PTC Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY